News and Insights

Pharmaceuticals and Medical Devices

Covid-19 Accelerates the Need for a New Commercial Model

As leadership focuses on the trauma of Covid-19 across healthcare delivery and the challenges it presents, it is easy to forget that the traditional commercial model was under serious stress before the pandemic. Consolidation across delivery, changes in product decision-making, and growing limitations on access were making that model increasingly…

The Numerof 2020 Global Medical Device Outlook

Infographic

As our Numerof 2020 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about adapting to pressures on price and demands for value. You’ll continue to engage in new and different ways with regulators, public and private payers, consumers, employers, health care delivery, physicians,…

The Numerof 2020 Global Pharma Outlook

Infographic

As our Numerof 2020 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value. This will create the need for changes in current roles and external relationships. You’ll continue to engage in new and different…

Big Pharma Needs a Better Business Model, Not More Legislation

Forbes

When the Trump administration dropped the drug rebate rule it introduced back in January – a rule that intended to prohibit pharmacy benefit managers (PBMs) from pocketing some of the rebates they should be passing along to patients – the decision sent shockwaves through the healthcare industry, particularly the pharma…